Natera has developed Signatera, a personalized ctDNA test for molecular residual disease detection and recurrence monitoring. Signatera's tumor-informed test has been validated in multiple solid tumors including melanoma for immunotherapy response monitoring. Dive deeper at www.natera.com/oncology
“As a commercial leader, I can testify to the great ROI we received this year. The PMWC conference provides us with a unique cross section of precision medicine key stakeholders and multiple ways to engage with them across the 3 day PMWC program. Our exhibit serves as a quality networking environment that puts us easily in touch with relevant new sales leads – at the right decision-making level.”
Head of Life Science and Healthcare, PMWC 2019 Exhibitor
The 17th PMWC offers exhibition options for emerging and established companies and organizations to promote their products and services. This is an opportunity for exhibitors to interact with PMWC participants actively involved and leading the personalized medicine revolution. In addition to standard networking, PMWC holds dedicated breaks from talks dedicated to exhibition where heavy foot-traffic flows:
This conference will take place at the Santa Clara Convention Center and as such will house a more traditional exhibition layout. The size spaces we offer are 10’x10′, 20’x10′ inline spaces & 22’x20′, 50’x20′ island spaces.